Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BrainChip Holdings - US Patent Granted (ASX:BRN)

Patent US 11,151,441 “System and Method for Spontaneous Machine Learning and Feature Extraction” is the fifth foundational patent awarded to BrainChip IP security remains a strong foc...read more

BrainChip Holdings - Appendix 4C and Quarterly Activities Report (ASX:BRN)

Cash Balance as at 30 September 2021 US$23.9M First batch of Akida1000 production chips delivered by Socionext Testing and evaluation of chips underway prior to delivery to customers Sydney,...read more

BrainChip Holdings - Top 20 Holders (ASX:BRN)

To view the announcement, download the attached PDF.

BrainChip Holdings - Taking Orders of Akida AI (ASX:BRN)

Brainchip to begin taking orders of two development kits both including the AKD1000 chip on a mini-PCI board Enables customers to begin internal testing and validation of Akida’s high-perfo...read more

Chimeric Therapeutics - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:CHM)

To view the report, download the attached PDF.

SUDA Pharmaceuticals - Chile Ministry of Health Approval Granted for ZolpiMist (ASX:SUD)

Chile approval achieved for SUDA’s ZolpiMist® This approval enables ZolpiMist to be marketed in Chile by SUDA’s partner, Teva Pharmaceuticals This is the first of Teva’s t...read more

AD1 Holdings - Voluntary suspension (ASX:AD1)

The securities of AD1 Holdings (‘AD1’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of AD1, pending the release of an announcement regarding a pro...read more

Altech Chemicals - Cleansing Statement - Exercise of Options (ASX:ATC)

On 20 October 2021, Altech Chemicals Limited (the "Company") issued 145,729 fully paid ordinary shares from the exercise of 145,729 quoted options (ASX: ATCOB). Accordingly the Company ...read more

Altech Chemicals - Application for quotation of securities (ASX:ATC)

To view the Application for quotation of +securities, download the attached PDF.

BARD1 Life Sciences - Amended Remuneration Table Directors Report (ASX:BD1)

The Company released its 2021 Annual Report on 29th September 2021. Subsequent to release, a typographical error was discovered in the ‘Remuneration of Key Management Personnel’ table wi...read more

Novatti Group - Acquisition of ATX presentation (ASX:NOV)

To view the presentation, download the attached PDF.

Novatti Group - Acquisition of leading South East Asian fintech (ASX:NOV)

Highlights -- Novatti to acquire Malaysia payments fintech ATX - recognised as a top 50 rising startup in South East Asia -- Large established payments network, including 30k+ touch points acros...read more

Novatti Group - Proposed issue of securities (ASX:NOV)

To view the Proposed issue of securities, download the attached PDF.

Sequoia Financial Group - Notice of Annual General Meeting/Proxy Form (ASX:SEQ)

In accordance with Listing Rule 3.17, Sequoia Financial Group Ltd (Sequoia or the Company) attaches a copy of the following documents: 1. Letter to Shareholders regarding arrangements for the Ann...read more

Acorn Capital Investment Fund - ACQ Cleansing Notice

This notice is given by Acorn Capital Investment Fund Limited ACN 167 595 897 (Company) under section 708AA(2)(f) of the Corporations Act 2001 (Cth) (Corporations Act) as modified by the Australian ...read more

Viewing: 1 - 15 of 200 Previous | Next